SV Life Sciences Closes $523M Venture Capital Fund
SV Life Sciences (SVLS), an international life sciences venture capital firm with offices in Boston, San Francisco and London, has held the final closing of its SV Life Sciences Fund V with total commitments of over $523m. Approximately 60% of capital commitments came from the United States and 40% from Europe and the rest of […]